Our Experts

In 2001, Chris began his career in London, England as an analyst for the international financial markets news agency Reuters. He later became an investigative reporter in his native Ireland. He worked for The Phoenix magazine, covering the real estate boom and bust there in the mid-2000s.

In 1978, Bill Bonner founded what is now the largest underground research network on the planet. Bill also co-wrote three New York Times bestselling books. His daily e-letter, Bill Bonner’s Diary, is published to over 500,000 readers.

Best-selling author, world-renowned speculator, and libertarian philosopher Doug Casey has garnered a well-earned reputation for his erudite (and often controversial) insights into politics, economics, and investment markets.

Jeff Brown is a high-technology executive with 25 years of experience. And that’s helped make him successful at identifying tech companies that are well-positioned for exponential growth.

Teeka Tiwari is the editor of Palm Beach Research Group’s flagship service The Palm Beach Letter, cryptocurrency advisory Palm Beach Confidential, Wall Street-beating newsletter Teeka Tiwari’s Alpha Edge, Palm Beach Crypto Income, Palm Beach Venture, and Palm Beach Infinity.

Before joining Brownstone Research, Jason spent nearly 20 years on Wall Street. He spent a total of 12 years at Cantor, including the final eight years as a partner and head of equity derivatives North America. He then traded and sold derivatives and ETFs for Jefferies.

Nick Rokke is a CPA and a CFA charterholder. He uses his analytical and market expertise to support Brownstone Research.

Originally from New York, Greg graduated from the University at Buffalo with a degree in accounting and received his MBA from Pace University, where he specialized in strategic management and finance.

John Pangere, CFA, is senior analyst for Strategic Investor and Strategic Trader. Each month, he teams up with David Forest to tell readers what’s happening in the world and where to find the best ways to profit.

Joe Withrow has over a decade of experience in corporate banking and was an early adopter of digital assets. He works behind the scenes as an analyst for Brownstone Research.

Dave is a geologist who has worked professionally in mining and petroleum over a 20-year career. He has also bridged his technical expertise into the finance and investment sector, originally joining Casey Research in 2004 when he…

Before entering the newsletter business, Grant was lead portfolio manager and head research analyst for a billion-dollar wealth manager. In his two decades in the investment industry, he developed a contact list of more than 500 top financial professionals.

Dan Denning is the coauthor of The Bonner-Denning Letter. Every month, he and Bill pen their contrarian thinking to help you look behind the curtain of Wall Street and big government.

Tom Dyson is the author of Postcards from the Fringe. Every day, he chronicles his insights on the economy, the markets, and life as he backpacks around the world.

William joined Palm Beach Research Group as lead analyst in August 2013. Since then, he's closed over 294 of 302 trades for a profit—a 97.4% win rate. He's now Teeka Tiwari’s chief analyst for options service Alpha Edge and for Palm Beach Venture.

Anthony Planas is an equity analyst for Palm Beach Venture and Alpha Edge. He joined Palm Beach Research Group in 2020 and specializes in spotting megatrends in sectors like legal cannabis, tech, and pre-IPOs.

Nilus is a widely recognized expert on income investments and retirement strategies, with a 15-year track record of winning ideas at the helm of various newsletters and trading services published by Weis Research, Agora Financial, and Standard & Poor’s. He’s now Teeka Tiwari’s chief analyst at The Palm Beach Letter.

Mike “Zappy” Zapolin is one of the foremost experts in psychedelic and plant-based medicinal therapies and companies. Zappy is a millionaire, investor, researcher, filmmaker, and adviser. His mission in life is to increase accessibility to psychedelic and plant-based compounds through education, research, clinical development, and commercial enterprises.